|
1
|
Grass GD, Cooper SL, Armeson K,
Garrett-Mayer E and Sharma A: Cervical esophageal cancer: A
population-based study. Head Neck. 37:808–814. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mendenhall WM, Sombeck MD, Parsons JT,
Kasper ME, Stringer SP and Vogel SB: Management of cervical
esophageal carcinoma. Semin Radiat Oncol. 4:179–191.
1994.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, et al:
Esophageal and esophagogastric junction cancers, version 1.2015. J
Natl Compr Canc Netw. 13:194–227. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lordick F, Mariette C, Haustermans K,
Obermannová R and Arnold D: ESMO Guidelines Committee. Oesophageal
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 27 (Suppl 5):v50–v57. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li G and Sturgis EM: The role of human
papillomavirus in squamous carcinoma of the head and neck. Curr
Oncol Rep. 8:130–139. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Allum WH, Stenning SP, Bancewicz J, Clark
PI and Langley RE: Long-term results of a randomized trial of
surgery with or without preoperative chemotherapy in esophageal
cancer. J Clin Oncol. 27:5062–5067. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5
and GP6 elongated at their 3'ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Riethdorf S, Riethdorf L, Milde-Langosch
K, Park TW and Löning T: Differences in HPV 16- and HPV 18 E6/E7
oncogene expression between in situ and invasive adenocarcinomas of
the cervix uteri. Virchows Arch. 437:491–500. 2000.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nishiwaki M, Yamamoto T, Tone S, Murai T,
Ohkawara T, Matsunami T, Koizumi M, Takagi Y, Yamaguchi J, Kondo N,
et al: Genotyping of human papillomaviruses by a novel one-step
typing method with multiplex PCR and clinical applications. J Clin
Microbiol. 46:1161–1168. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sobin LH and Wittekind C (eds): TNM
classification of malignant tumorurs, 6th edition. John Wiley &
Sons, Hoboken, NJ, 2002.
|
|
12
|
Li X, Gao C, Yang Y, Zhou F, Li M, Jin Q
and Gao L: Systematic review with meta-analysis: The association
between human papillomavirus infection and oesophageal cancer.
Aliment Pharmacol Ther. 39:270–281. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Goto A, Li CP, Ota S, Niki T, Ohtsuki Y,
Kitajima S, Yonezawa S, Koriyama C, Akiba S, Uchima H, et al: Human
papillomavirus infection in lung and esophageal cancers: Analysis
of 485 Asian cases. J Med Virol. 83:1383–1390. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu MY, Liang YR, Wu XY and Zhuang CX:
Relationship between Egr-1 gene expression and apoptosis in
esophageal carcinoma and precancerous lesions. World J
Gastroenterol. 8:971–975. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li QD, Li H, Wang MS, Diao TY, Zhou ZY,
Fang QX, Yang FY and Li QH: Multi-susceptibility genes associated
with the risk of the development stages of esophageal squamous cell
cancer in Feicheng County. BMC Gastroenterol. 11(74)2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yasuda M, Kuwano H, Watanabe M, Toh Y,
Ohno S and Sugimachi K: p53 expression in squamous dysplasia
associated with carcinoma of the oesophagus: Evidence for field
carcinogenesis. Br J Cancer. 83:1033–1038. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Montesano R, Hollstein M and Hainaut P:
Genetic alterations in esophageal cancer and their relevance to
etiology and pathogenesis: A review. Int J Cancer. 69:225–235.
1996.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhan C, Yan L, Wang L, Jiang W, Zhang Y,
Xi J, Jin Y, Chen L, Shi Y, Lin Z and Wang Q: Landscape of
expression profiles in esophageal carcinoma by the cancer genome
atlas data. Dis Esophagus. 29:920–928. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang K, Johnson A, Ali SM, Klempner SJ,
Bekaii-Saab T, Vacirca JL, Khaira D, Yelensky R, Chmielecki J,
Elvin JA, et al: Comprehensive genomic profiling of advanced
esophageal squamous cell carcinomas and esophageal adenocarcinomas
reveals similarities and differences. Oncologist. 20:1132–1139.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shigaki H, Baba Y, Watanabe M, Miyake K,
Murata A, Iwagami S, Ishimoto T, Iwatsuki M, Yoshida N and Baba H:
KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas:
Pyrosequencing technology and literature review. Ann Surg Oncol. 20
(Suppl 3):S485–S491. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cui Y, Chang D, Liu M, Lin C, Zhao B,
Zhang X and Gong M: Identification of exon 19 and 21 mutations of
EGFR gene in Chinese patients with esophageal squamous cell
carcinoma. World J Surg Oncol. 11(266)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dutton SJ, Ferry DR, Blazeby JM, Abbas H,
Dahle-Smith A, Mansoor W, Thompson J, Harrison M, Chatterjee A,
Falk S, et al: Gefitinib for oesophageal cancer progressing after
chemotherapy (COG): A phase 3, multicentre, double-blind,
placebo-controlled randomised trial. Lancet Oncol. 15:894–904.
2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Petty RD, Dahle-Smith A, Stevenson DAJ,
Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C,
Chong IY, et al: Gefitinib and EGFR gene copy number aberrations in
esophageal cancer. J Clin Oncol. 35:2279–2287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Matlung SE, Wilhelmina van Kempen PM,
Bovenschen N, van Baarle D and Willems SM: Differences in T-cell
infiltrates and survival between HPV+ and HPV-oropharyngeal
squamous cell carcinoma. Future Sci OA. 2(FSO88)2016.PubMed/NCBI View Article : Google Scholar
|
